Me too. This is a very compelling argument that if implemented could save many lives. https://twitter.com/RMedzhitov/status/1355546700685963264 …
-
-
I wish we started a trial back in December but here we are. Q: I wish there were models for starting with one dose but then at some point moved to boosters (for elderly going down by age) while expanding one shot for younger groups: varying correlates of protection assumptions.
-
The reason I say this is now we see places like UK that just seems to have moved to all one-shot strategy (no trial) while here in the US we are doing two-doses for Pfizer on three-weeks to booster strategy when WHO/CDC both say six weeks okay but not differentiating by risk/age.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.